EC Clinical and Medical Case Reports

Short Communication Volume 6 Issue 1 - 2023

Non Alcoholic Fatty Liver Disease and Increased Intima Media Thickness as Markers of Subclinical Atherosclerosis in Severe Obesity

Carmine Finelli*

Department of Internal Medicine, ASL Napoli 3 Sud, Via di Marconi, Torre del Greco, Napoli, Italy

*Corresponding Author: Carmine Finelli, Department of Internal Medicine, ASL Napoli 3 Sud, Via di Marconi, Torre del Greco, Napoli, Italy.
Received: November 28, 2022; Published: December 10, 2022




Metabolic Syndrome (MS) and overweight/obesity incidence rates are both sharply rising. According to the widely held belief, being overweight has less severe but yet comparable health effects as being obese. Throughout all age ranges and the range of minor and significant increases in body weight, the probability of death from all exerted a profound influence including both men and women [1].

  1. Flegal KM., et al. “Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis”. Journal of the American Medical Association 1 (2013): 71-82.
  2. Juanola O., et al. “Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors”. International Journal of Environmental Research and Public Health 10 (2021): 5227.
  3. Calcaterra V., et al. “The Effect of Healthy Lifestyle Strategies on the Management of Insulin Resistance in Children and Adolescents with Obesity: A Narrative Review”. Nutrients21 (2022): 4692.
  4. Kong M., et al. “Assessing Visceral Obesity and Abdominal Adipose Tissue Distribution in Healthy Populations Based on Computed Tomography: A Large Multicenter Cross-Sectional Study”. Frontiers in Nutrition 9 (2022): 871697.
  5. Mascaró CM., et al. “Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review”. Nutrients1 (2021): 49.
  6. Kelso A., et al. “Ultrasound measurements of subcutaneous adipose tissue thickness show sexual dimorphism in children of three to five years of age”. Acta Paediatrica 3 (2019): 514-521.
  7. Cataldo I., et al. “Pathology of non-alcoholic fatty liver disease”. Pathologica3 (2021): 194-202.
  8. Scapaticci S., et al. “Non-Alcoholic Fatty Liver Disease in Obese Youth with Insulin Resistance and Type 2 Diabetes”. Frontiers in Endocrinology (Lausanne) 12 (2021): 639548.
  9. Di Pino A and DeFronzo RA. “Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents”. Endocrine Reviews 6 (2019): 1447-1467.
  10. Drożdż D., et al. “Endothelial dysfunction as a factor leading to arterial hypertension”. Pediatric Nephrology (2022).
  11. Mastromauro C., et al. “Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes”. Current Opinion in Pediatrics 4 (2022): 414-422.
  12. Marchesini G., et al. “Association of nonalcoholic fatty liver disease with insulin resistance”. American Journal of Medicine 5 (1999): 450-455.
  13. Mandraffino G., et al. “Fatty Liver as Potential Biomarker of Atherosclerotic Damage in Familial Combined Hyperlipidemia”. Biomedicines8 (2022): 1770.
  14. Qi X and Lai J. “Exosomal microRNAs and Progression of Nonalcoholic Steatohepatitis (NASH)”. International Journal of Molecular Sciences 21 (2022): 13501.
  15. Theofilis P., et al. “Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis”. Life (Basel)5 (2022): 718.
  16. Nasiri-Ansari N., et al. “Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review”. Cells16 (2022): 2511.
  17. Özbiçer S., et al. “Triglyceride glucose index is independently associated with aortic intima-media thickness in patients without known atherosclerotic cardiovascular disease or diabetes”. Diabetes and Vascular Disease Research 5 (2022): 14791641221136203.
  18. Mota-Zamorano S., et al. “Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy”. Annals of Medicine 1 (2022): 3039-3051.
  19. Pacifico L., et al. “Carotid Extra-Media Thickness in Children: Relationships with Cardiometabolic Risk Factors and Endothelial Function”. Frontiers in Endocrinology (Lausanne) 11 (2020): 574216.
  20. Liu KH., et al. “Sonographic Measurement of Mesenteric Fat Thickness Is a Better Predictor of Aortic Stiffness Compared with Conventional Obesity Indexes”. Ultrasound in Medicine and Biology (2022).

Carmine Finelli. Non Alcoholic Fatty Liver Disease and Increased Intima Media Thickness as Markers of Subclinical Atherosclerosis in Severe Obesity. EC Clinical and Medical Case Reports   6.1 (2023): 14-16.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net